Literature DB >> 29374532

Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.

Mohsin Vahid Khan1, Syed Mohammad Zakariya1, Rizwan Hasan Khan2.   

Abstract

The newly synthesized unfolded polypeptide attains its functional and unique three-dimensional conformation through the process of protein folding for which several models have been proposed. The protein misfolding diseases include Alzheimer's, Parkinson's and Cataract which are result of formation of amyloid or amorphous aggregates, respectively. The distinction in morphology shows relation with the melting temperature (Tm). The temperatures near or slightly higher than Tm induces amyloids while much higher or low temperature mediate amorphous aggregation. The aggregation is not always deleterious rather it also performs several important cellular functions essential for survival wide range of organisms called as functional amyloids. Protein gets modulated by several modulators which mediate the aggregation, acceleration, delay, transformations, inhibition and disaggregation of protein aggregates. The exclusive properties of inhibition and disaggregation displayed by various molecules can be employed to treat the life threatening disorders.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid; Dyes; Modulators

Mesh:

Substances:

Year:  2018        PMID: 29374532     DOI: 10.1016/j.ijbiomac.2018.01.099

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

Review 1.  Reversible, functional amyloids: towards an understanding of their regulation in yeast and humans.

Authors:  Gea Cereghetti; Shady Saad; Reinhard Dechant; Matthias Peter
Journal:  Cell Cycle       Date:  2018-08-02       Impact factor: 4.534

2.  A molecular simulation approach towards the development of universal nanocarriers by studying the pH- and electrostatic-driven changes in the dynamic structure of albumin.

Authors:  Amit Kumar Srivastav; Sanjeev K Gupta; Umesh Kumar
Journal:  RSC Adv       Date:  2020-04-02       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.